Brendan Hannah
CIK 1929422 · CBO, COO & CCO · last filed 2026-01-23
Brendan Hannah is a CBO, COO & CCO who has filed 12 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for QNCX, was dated Jan 23, 2026. Across all open-market trades the lifetime net is +$111.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $314.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$314.2K
2
12
$111.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QNCX | CBO, COO & CCO | 336,547 | $0.93 | $314.2K | $111.7K | 10 | 2026-01-23 |
| Quince Therapeutics, Inc. (CRTX) Delisted | Chief Business Officer | 129,793 | $1.95 | $253.1K | $0 | 2 | 2022-05-27 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-23 | QNCX | Grant (A) | — | $0 | EDGAR |
| 2025-12-08 | QNCX | Exer (M) | +27,551 | $25.0K | EDGAR |
| 2025-06-23 | QNCX | Grant (A) | +37,736 | $45.3K | EDGAR |
| 2025-02-11 | QNCX | Grant (A) | — | $0 | EDGAR |
| 2024-08-21 | QNCX | Buy (P) | +38,924 | $24.2K | EDGAR |
| 2024-06-05 | QNCX | Exer (M) | +56,061 | $30.8K | EDGAR |
| 2024-02-02 | QNCX | Grant (A) | — | $0 | EDGAR |
| 2023-10-26 | QNCX | Grant (A) | — | $0 | EDGAR |
| 2023-08-09 | QNCX | Buy (P) | +71,762 | $87.5K | EDGAR |
| 2023-02-02 | QNCX | Grant (A) | — | $0 | EDGAR |